Technical analysis of Inovio Pharmaceuticals, Inc. (INO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen.
Price Performance
| 1 month | -4.17% |
| 3 months | +2.68% |
| Year-to-date | -33.91% |
| 1 year | -47.25% |
| 3 years | -76.04% |
| 5 years | -98.82% |
52-Week Range
| 52-week High | $2.72 |
| 52-week Low | $0.56 |
| Avg Volume (90d) | 3.5M |
Technical Indicators
| SMA 50 | $1.09 |
| SMA 200 | $1.41 |
| Beta | 1.70 |
| 30-day Volatility (annualised) | 92.2% |
| Price vs SMA 50 | +5.5% |
| Price vs SMA 200 | -18.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.35 | |
| 2025-11 | $2.06 | -12.3% |
| 2025-12 | $1.74 | -15.5% |
| 2026-01 | $1.63 | -6.3% |
| 2026-02 | $1.81 | +11.0% |
| 2026-03 | $1.74 | -3.9% |
| 2026-04 | $1.12 | -35.6% |
| 2026-05 | $1.31 | +17.0% |
| 2026-06 | $1.10 | -16.0% |
| 2026-07 | $0.68 | -38.5% |
| 2026-08 | $1.27 | +87.6% |
| 2026-09 | $1.15 | -9.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
Price
| Price | $1.15 |
| Market Cap | $79M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.72 |
| EV / EBITDA | -0.57 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.39 |
| Current Ratio | 1.40 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -36.80 |